Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.200 | None | 1.000 | 7 | 0 | 1985 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.500 | None | 0.983 | 41 | 0 | 1990 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 25 | 0 | 1990 | 2019 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 1990 | 2017 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1990 | 2014 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.390 | None | 1.000 | 3 | 0 | 1990 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 1990 | 2006 | ||||||||
|
ornithine decarboxylase 1 | 0.510 | 0.731 | 0.17 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 1990 | 2011 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 1990 | 2003 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.989 | 35 | 0 | 1991 | 2018 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.050 | None | 1.000 | 1 | 0 | 1991 | 2013 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
group | 0.040 | None | 1.000 | 1 | 0 | 1991 | 2017 | ||||||||
|
gastrin | 0.485 | 0.808 | 2.7E-03 |
|
group | 0.050 | None | 0.800 | 3 | 0 | 1992 | 2007 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
group | 0.380 | None | 1.000 | 3 | 0 | 1992 | 2007 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
group | 0.100 | None | 1.000 | 4 | 0 | 1993 | 2015 | ||||||||
|
matrix metallopeptidase 7 | 0.446 | 0.885 | 1.0E-09 |
|
group | 0.100 | None | 0.923 | 7 | 0 | 1994 | 2014 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
group | 0.340 | None | 1.000 | 3 | 0 | 1994 | 2005 | ||||||||
|
trefoil factor 1 | 0.529 | 0.769 | 8.9E-04 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 1994 | 2004 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.100 | None | 1.000 | 7 | 0 | 1995 | 2013 | ||||||||
|
matrix metallopeptidase 11 | 0.542 | 0.692 | 2.4E-05 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 1995 | 2008 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
group | 0.400 | None | 1.000 | 20 | 0 | 1996 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1996 | 2008 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
group | 0.100 | None | 1.000 | 9 | 0 | 1996 | 2008 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.100 | None | 1.000 | 8 | 0 | 1996 | 2008 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.700 | None | 1.000 | 7 | 0 | 1996 | 2016 |